StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Eli Lilly (LLY) PT Raised to $1,050 at Jefferies
August 2, 2024 7:06 AM
Jefferies analyst Akash Tewari raised ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Next Articles
Lilly CEO says weight-loss drug shortage to end 'very soon', Bloomberg News reports
August 1, 2024 1:37 PM
Midday movers: Meta Platforms, Lilly rise; Arm, Moderna fall
August 1, 2024 8:07 AM
Eli Lilly stock gains on new weight-loss drug study results, Novo Nordisk down
August 1, 2024 7:48 AM
Eli Lilly & Co. (LLY) reports tirzepatide successful in phase 3 study showing benefit in adults with heart failure with preserved ejection fraction and obesity
August 1, 2024 6:47 AM
Lilly's tirzepatide successful in phase 3 study showing benefit in adults with heart failure with preserved ejection fraction and obesity
August 1, 2024 6:45 AM
